Antihypertensive Effect of Piper Sarmentosum in L - Induced Hypertensive Rats
Antihypertensive Effect of Piper Sarmentosum in L - Induced Hypertensive Rats
Antihypertensive Effect of Piper Sarmentosum in L - Induced Hypertensive Rats
http://dx.doi.org/10.17576/jsm-2018-4710-18
NIK ALOESNISA NIK MOHD ALWI, ZAITON ZAKARIA, AMINUDDIN ABDUL HAMID KARIM,
NOR ANITA MEGAT MOHD NORDIN & AZIZAH UGUSMAN*
ABSTRACT
Hypertension is one of the risk factors for cardiovascular diseases and has been associated with about 13% of global deaths
worldwide. Oxidative stress and reduced nitric oxide (NO) bioavailability contribute to the development of endothelial
dysfunction and subsequently hypertension. Nɷ-nitro-L-arginine methyl ester hydrochloride (L-NAME) inhibits NO synthesis;
leading to hypertension. Piper sarmentosum (PS) is an herb with antioxidant, antiatherosclerosis and antiinflammation
properties. PS also stimulated NO production by endothelial cells. The aim of this study was to determine the effects of
aqueous extract of Piper sarmentosum (AEPS) on blood pressure, oxidative stress and the level of nitric oxide in L-NAME-
induced hypertensive rats. Hypertension was induced by oral administration of L-NAME (100 mg/L) in drinking water for
four weeks. The rats were concurrently treated with AEPS by oral gavage in serial doses (125, 250 and 500 mg/kg/day).
Blood pressure was measured using non-invasive tail-cuff method at baseline and fortnightly thereafter. Serum level of
NO and an oxidative stress marker, malondialdehyde (MDA) were measured at baseline and at the end of treatment. The
results showed that treatment with three different doses of AEPS successfully reduced systolic blood pressure (p<0.001),
diastolic blood pressure (p<0.05) and mean arterial pressure (p<0.05) in L-NAME-induced hypertensive rats. Treatment
with AEPS also reduced MDA level (p<0.001) and increased serum NO (p<0.001) in L-NAME-induced hypertensive rats.
The findings showed that AEPS decreased blood pressure by protecting against oxidative stress and increasing NO in
L-NAME-induced hypertensive rats.
Keywords: Hypertension; nitric oxide; Nɷ-nitro-L-arginine methyl ester hydrochloride; oxidative stress; Piper sarmentosum
ABSTRAK
Hipertensi merupakan salah satu faktor risiko penyakit kardiovaskular dan ia dikaitkan dengan kira-kira 13% kematian
di seluruh dunia. Stres oksidatif dan pengurangan ketersediaan biologi nitrik oksida (NO) menyumbang kepada
terjadinya disfungsi endotelium yang seterusnya menyebabkan hipertensi. Nɷ-nitro-L-arginina metil ester hidroklorida
(L-NAME) merencat sintesis NO dan menyebabkan hipertensi. Piper sarmentosum (PS) adalah herba yang mempunyai
sifat antioksidan, antiaterosklerosis dan antiinflamasi. PS juga merangsang pengeluaran NO oleh sel endotelium. Tujuan
kajian ini adalah untuk menentukan kesan ekstrak akueus Piper sarmentosum (AEPS) terhadap tekanan darah, stres
oksidatif dan aras nitrik oksida dalam tikus hipertensi aruhan L-NAME. Hipertensi diaruh dengan pemberian L-NAME
(100 mg/L) secara oral di dalam air minuman selama empat minggu. Dalam masa yang sama, rawatan tikus dengan
AEPS turut diberi serentak melalui gavaj oral dalam dos bersiri (125, 250 dan 500 mg/kg/hari). Tekanan darah diukur
menggunakan kaedah kuf ekor tidak invasif sebelum rawatan dimulakan dan setiap dua minggu selepas itu. Aras serum
NO dan penanda stres oksidatif, malondialdehida (MDA) diukur sebelum uji kaji dimulakan dan selepas rawatan tamat.
Keputusan menunjukkan rawatan dengan tiga dos AEPS yang berbeza berjaya menurunkan tekanan darah sistolik (p<
0.001), tekanan darah diastolik (p<0.05) dan tekanan arteri purata (p<0.05) dalam tikus hipertensi aruhan L-NAME. AEPS
juga menurunkan aras MDA (p<0.01) dan meningkatkan aras NO (p<0.001) dalam serum tikus hipertensi aruhan L-NAME.
Keputusan yang diperoleh menunjukkan bahawa AEPS berupaya menurunkan tekanan darah dengan mengurangkan stres
oksidatif dan meningkatkan aras NO pada tikus hipertensi aruhan L-NAME.
Kata kunci: Hipertensi; nitrik oksida; Nɷ-nitro-L-arginina metil ester hidroklorida; Piper sarmentosum; stres oksidatif
Endothelial dysfunction (ED) has been observed in Zainudin et al. 2013). Briefly, the leaves of PS were oven-
the early stage of hypertension and it is the commonest dried for 36 h at 50°C. Then the dried leaves were cut into
contributing factor to hypertension (Park & Park 2015). small pieces and crushed. 10 g of dried leaves were mixed
Several studies had suggested that oxidative stress with 900 mL of distilled water. Hot water extraction was
contributed to the development of hypertension through prepared by boiling the mixture at 80°C for 3 h. Then, the
nitric oxide (NO) inactivation (Baradaran et al. 2014; Sinha extract was concentrated and freeze-dried into powder
& Kumar Dabla 2015). Increased free radical production as form. It was stored at 4°C until use.
well as imbalance between the level of NO and endothelial
vasoconstrictors such as endoperoxides, endothelins EXPERIMENTAL ANIMALS
and thromboxane A lead to endothelial dysfunction and
hypertension (Davidge et al. 2015; Panth et al. 2016; This study had been approved by the Animal Ethics
Vanhoutte et al. 2017). Committee, Universiti Kebangsaan Malaysia (approval
Many methods to induce hypertension had been code: PP/FISIO/2011/AMINUDDIN/22-MARCH/360-JUNE-
used in animal models. Nω-nitro-L-arginine methyl ester 2011-JUNE-2012). Healthy adult male Wistar rats, aged 6
hydrochloride (L-NAME), an L-arginine analogue, acts to 8 weeks, weighing between 170-220 g were obtained
as a competitive inhibitor of non-specific nitric oxide from the Laboratory Animal Resource Unit, Universiti
synthases (NOS). L-NAME has been widely used to create Kebangsaan Malaysia. The rats were maintained in an
NO-deficient hypertensive model. It is well established air-conditioned room at 23 ± 3°C and were housed in
that inhibition of nitric oxide biosynthesis by in vivo individual cages with a 12-h light and 12-h dark cycle.
administration of L-NAME causes endothelial dysfunction The rats were provided with normal rat chow and clean
and vasoconstriction, hence leading to hypertension (Raja drinking water ad libitum. The rats were acclimatized for
2010). one week before the experiment started.
Piper sarmentosum is a herb that had been reported
to have antioxidant activity (Hafizah et al. 2010). Toxicity EXPERIMENTAL DESIGN AND INDUCTION
studies on aqueous extract of PS showed that the extract is OF HYPERTENSION
safe for consumption (Mohd Zainudin et al. 2013). Previous Thirty six animals were divided into six groups with six
studies had reported various medicinal effects of PS such as animals in each group (n=6): control group; Aqueous
antihyperglycemia (Azlina et al. 2009), antiatherosclerosis extract Piper sarmentosum (AEPS) only group where the
(Amran et al. 2010), anticarcinogenesis (Ariffin et al. 2009) rats were given 500 mg/kg/day AEPS via oral gavage;
and antiinflammation (Ridtitid et al. 2007; Zakaria et al. L-NAME-induced hypertensive group was given 100 mg/L
2010). Apart from that, PS is also able to protect against L-NAME in drinking water and three groups of L-NAME-
glucocorticoid-induced osteoporosis (Mohamad Asri et induced-hypertensive rats with co-treatment of different
al. 2016) and paracetamol-induced oxidative liver injury doses of AEPS; 100 mg/L L-NAME and 125 mg/kg/day AEPS;
(Azlina et al. 2014). Previous studies had shown that PS is 100 mg/L L-NAME and 250 mg/kg/day AEPS; and 100 mg/L
able to reduce blood pressure in spontaneously hypertensive L-NAME and 500 mg/kg/day AEPS. The treatments were
rats (SHR) (Zainudin et al. 2015). Aqueous extract of PS is given for four weeks (Wheal et al. 2007). Group 2 was
able to stimulate NO production in human umbilical vein included in this study to investigate whether AEPS on its
endothelial cells (HUVECs) (Ugusman et al. 2012). This own could affect the parameters measured in this study. All
suggests that PS may regulate blood pressure via the NO the three doses of AEPS were adopted from previous study
pathway. Therefore, this study was designed to determine on anti-atherosclerosis effect of AEPS (Amran et al. 2010).
the effects of PS on blood pressure, oxidative stress and
NO level in L-NAME-induced hypertensive Wistar rats.
DETERMINATION OF BLOOD PRESSURE
Systolic blood pressure (SBP), diastolic blood pressure
MATERIALS AND METHODS (DBP) and mean arterial pressure (MAP) were measured
in non-anaesthetized rats by non-invasive tail-cuff CODA
PLANT MATERIALS blood pressure system (Kent Scientific Corporation, USA)
Fresh leaves of PS were collected in Selayang, Selangor, at baseline and every two weeks after starting treatment
Malaysia between January to February 2012 and were (Zainudin et al. 2015). At least five readings were recorded
identified by a plant taxonomist from the Medicinal Plant during each measurement. The maximum and minimum
Division, Forest Research Institute of Malaysia with plant values were discarded and the remaining three values were
identification number (PID) 170612-11. calculated as the average (Si & Liu 2008; Yang et al. 2008).
*p<0.001 versus L-NAME group within the same week, # p<0.001 versus pre-treatment group
FIGURE 1. Effect of AEPS on systolic blood pressure (SBP) in L-NAME induced hypertensive rats
2424
*p<0.05 versus L-NAME within the same week, # p<0.01 versus pre-treatment group
FIGURE 2. Effect of AEPS on diastolic blood pressure (DBP) in L-NAME induced hypertensive rats
no significant difference in DBP between the three doses the end of treatment (97.0 ± 3.44, 101.2 ± 1.86 and 100.5
of AEPS following two and four weeks of treatment. In ± 2.71 mmHg, respectively) (p<0.05). However, there was
addition, administration of AEPS alone did not significantly no significant difference in MAP between the three doses
alter the DBP compared to control. of AEPS following two and four weeks of treatment. In
addition, administration of AEPS alone did not significantly
EFFECT OF AEPS ON MEAN ARTERIAL BLOOD PRESSURE
alter the MAP compared to control.
The changes in MAP were in accordance to changes in SBP
and DBP. At baseline, there was no significant difference in EFFECTS OF AEPS ON SERUM NO
MAP among the groups. Following two weeks of treatment, L-NAME induction caused reduction of serum NO compared
L-NAME-induced rats had higher MAP (126.0 ± 2.45 mmHg) to its pre-induction level (4.5 ± 1.92 vs 40.7 ± 6.26
as compared to control rats (96.7 ± 0.88 mmHg) (p<0.05). μM, p<0.05) as well as compared to control (p<0.001).
Treatment of L-NAME-induced rats with all three doses of Treatment with all three doses of AEPS (125, 250, 500 mg/
AEPS successfully reduced MAP (104.7 ± 4.97, 98.8 ± 3.93 kg/day) increased serum NO compared to L-NAME group
and 97.8 ± 6.89 mmHg) (p<0.05). At the end of the four (p<0.001) with the values of 56.33 ± 9.15, 80.88 ± 8.55
weeks treatment, the MAP of L-NAME-induced rats were and 75.02 ± 8.46 μM, respectively. Apart from that, there
persistently high compared to control (142.0 ± 4.49 vs. 91.2 was significant difference in the level of NO before and
± 1.78 mmHg, p< 0.05). Treatment of L-NAME-induced rats after treatment in AEPS, L-NAME + AEPS 250 mg/kg/day and
with all three doses of AEPS significantly reduced MAP at L-NAME + AEPS 500 mg/kg/day groups (p<0.05).
FIGURE 3. Effect of AEPS on mean arterial pressure (MAP) in L-NAME induced hypertensive rats
2425
EFFECT OF AEPS ON SERUM MDA contributes to EH (Arora et al. 2009). Increased in free
Four weeks following L-NAME induction, serum MDA was radical generation inactivates prostacyclin and NO, hence
increased compared to its pre-induction level (65.59 ± causing half-life of prostacyclin and NO to be decreased.
5.46 vs. 23.81 ± 4.33 nmol/g protein, p<0.01) as well as This situation may lead to increase in peripheral vascular
compared to control (p<0.05). Treatment with all three resistance and subsequently hypertension (Kumar &
doses of AEPS (125, 250, 500 mg/kg/day) reduced serum Das 1993). Basal production of NO was reduced in
MDA level compared to L-NAME group (p<0.05) with the spontaneously hypertensive rats (SHR) (Dohi et al. 1990).
values of 22.70 ± 3.63, 16.57 ± 4.64 and 25.15 ± 11.39 The endothelium-dependant vasodilator responses
nmol/g protein, respectively. were attenuated in patients who suffered from essential
hypertension which was mainly contributed to reduced
bioactivity of NO (Panza et al. 1990).
DISCUSSION The main objective in this study was to evaluate whether
Hypertension is categorized into primary or essential the high blood pressure in NO-deficient hypertensive
hypertension (EH) and secondary hypertension. More than rats induced by L-NAME, an L-arginine analogue that
90% of hypertensive patients have EH whereby the cause inhibits nitric oxide synthases could be improved by
is still unclear. Current studies suggest that NO deficiency AEPS treatment. In the present study, the administration
of L-NAME in drinking water had induced hypertension (Nox4) expressions in oxidative stress-induced HUVECs.
in rats which concurred with previous studies (Raja Nox4 is the predominant enzyme for ROS production
2010). Concomitant treatment with serial doses of AEPS in endothelial cells (Ugusman et al. 2010). Several
in the L-NAME-induced hypertensive rats had significantly chemical compounds with antioxidant activities found in
attenuated the hypertension. PS are polyphenols, vitamins C and E, carotenes, tannins,
Nitric oxide produced by endothelial nitric oxide xanthophylls, flavonoids and amides (Hussain et al. 2015).
synthase (e NOS ) is the major source of circulating Polyphenols had been shown to reduce blood pressure in
NO. L-NAME interferes with the activity of e NOS, thus NO-deficient model of hypertension (Bernátová et al. 2002;
reducing NO production (Raja 2010). Since NO is a Rodrigo et al. 2016). Since this study used crude extract
potent vasodilator, decreased NO production may impair of PS and not its isolated bioactive components, this study
endothelial-dependent vasodilation, causing increased was unable to specify the active compound responsible
peripheral resistance and blood pressure (Park & Park for the antihypertensive effect. However, it is suggested
2015). Previous study had proven that PS increased NO level that the antihypertensive effect of PS in NO-deficient
by stimulating eNOS expression and activity in HUVECs model of hypertension observed in this study is due to its
(Ugusman et al. 2010). Therefore, increased level of NO polyphenols content.
in L-NAME-induced hypertensive rats treated with AEPS
could be due to increase in the activity of eNOS. A study CONCLUSION
by Ugusman et al. (2014) had found that a flavonoid,
rutin, one of the compound in Piper sarmentosum, may AEPS reduces blood pressure in L-NAME -induced
improve endothelial function by augmenting NO production hypertensive rats and the antihypertensive effect may be
in HUVEC. Another recent study on PS showed that the partly mediated by increased NO and reduced oxidative
extract was able to reduce blood pressure by increasing stress. Our findings suggest that AEPS has the potential
NO production in SHR (Zainudin et al. 2015). to be developed as a therapeutic agent for hypertension.
Apart from inhibiting NO synthesis, L-NAME induces However, further studies using isolated bioactive
hypertension by causing oxidative stress. L-NAME is components from AEPS are required in order to support the
responsible to cause imbalance in renin-angiotensin therapeutic potential of AEPS for hypertension.
system (RAS) whereby it increased the expression of
angiotensin II and also caused renal dysfunction (Rincon ACKNOWLEDGEMENTS
et al. 2015). The excessive production of angiotensin
This study was funded by UKMMC Fundamental Research
II leads to increase vascular superoxide (O2-) formation
Fund (FF-174-2011). The authors express their sincere
through increased expression of NADPH-dependent oxidase
thanks to the staff of Physiology Department; Norizam
in aortic smooth muscle cells (Tsai et al. 2016). The
Salamt, Fadzilah Mohd Suratman, Zanariyah Asmawi,
excessive O2- react rapidly with NO to form peroxynitrite
Musmarlina Omar, Aini Farzana Zulkefli and Kamariah
(ONOO−). Peroxynitrite is a strong pro-oxidant molecule
Othman for the technical assistance.
which causes lipid peroxidation and tissue injury (Hogg
et al. 2017). In addition, hypertension itself leads to
enhanced production of ROS. Previous studies had shown REFERENCES
that in different models of systemic hypertension, there Amran, A.A., Zakaria, Z., Othman, F., Das, S., Raj, S. & Nordin,
would be enhancement of O2- and superoxide-producing N.A.M. 2010. Aqueous extract of Piper sarmentosum
enzymes, regardless of how the hypertension was induced decreases atherosclerotic lesions in high cholesterolemic
(Drummond & Sobey 2014; García-Redondo et al. 2016). experimental rabbits. Lipids in Health and Disease 9: 44.
Ariffin, S.H.Z., Omar, W.H.H.W., Ariffin, Z.Z., Safian, M.F.,
Malondialdehyde exists in the serum, plasma, tissues as
Senafi, S. & Wahab, R.M.A. 2009. Intrinsic anticarcinogenic
well as in the urine. It is the commonest analytic estimation effects of Piper sarmentosum ethanolic extract on a human
of lipid peroxidation and oxidative stress that has been hepatoma cell line. Cancer Cell International 9: 6.
reported (Chen et al. 2015). In the present study, the level Arora, S., Das, N. & Srivastava, K. 2009. Nitric oxide and
of MDA was increased in the L-NAME-induced hypertensive eNOS gene in essential hypertension. International Journal
rats; indicating that oxidative stress plays an important of Collaborative Research on Internal Medicine and Public
role in the pathophysiology of hypertension (Baradaran Health (IJCRIMPH) 1: 56-71.
et al. 2014). Treatment of L-NAME-induced hypertensive Azlina, A.A., Farihah, H., Qodriyah, H. & Nur, A. 2009. Effects
rats with AEPS caused reduction in MDA level. This of Piper sarmentosum water extract on 11-β hydroxysteroid
dehydrogenase Type 1 bioactivity in ovariectomy-induced
finding is in accordance to a recent study which showed
obese rats. IJP-International Journal of Pharmacology 5:
that PS significantly reduced MDA level in spontaneously 362-369.
hypertensive rats (Zainudin et al. 2015). Azlina, M., Qodriyah, H., Hamizah, A. & Kamisah, Y. 2014.
Decreased level of MDA in AEPS treated group could Effects of methanolic extract of Piper sarmentosum on
be attributed to the antioxidant effects of PS. PS had been paracetamol-induced hepatic oxidative injury in rats. Sains
proven to have strong antioxidant activity (Ugusman et al. Malaysiana 43(3): 415-421.
2012). Besides, PS had been shown to suppress intercellular Baradaran, A., Nasri, H. & Rafieian-Kopaei, M. 2014. Oxidative
adhesion molecule-1 ( ICAM-1) and NADPH oxidase 4 stress and hypertension: Possibility of hypertension therapy
2427
with antioxidants. Journal of Research in Medical Sciences: Park, K.H. & Park, W.J. 2015. Endothelial dysfunction: Clinical
The Official Journal of Isfahan University of Medical implications in cardiovascular disease and therapeutic
Sciences 19(4): 358-367. approaches. Journal of Korean Medical Science 30: 1213-
Bernátová, I., Pechánová, O., Babál, P., Kyselá, S., Stvrtina, S. 1225.
& Andriantsitohaina, R. 2002. Wine polyphenols improve Pessoa, L.M.B., Lima, M.G.d.M., Carneiro, F.T., Zanani, N.S.,
cardiovascular remodeling and vascular function in NO- Scalon, M.C., Silva, T.F., Lima, M.A., Abrahim, M.A.
deficient hypertension. American Journal of Physiology- & Paludo, G.R. 2017. Refractometry as an alternative to
Heart and Circulatory Physiology 282: H942-H948. the biuret method for measuring total serum proteins in
Borges, A., Piassão, J., Paula, M., Sepp, S., Bez, C., Hepp, L., Podocnemis expansa (Podocnemididae) and Phrynops
Valduga, A., Pereira, A. & Cansian, R. 2018. Characterization geoffroanus (Chelidae). Acta Amazonica 47: 83-86.
of oxidative stress biomarkers in a freshwater anomuran crab. Raja, B. 2010. Antihypertensive and antioxidant potential of
Brazilian Journal of Biology 78: 61-67. borneol-a natural terpene in L-NAME-induced hypertensive
Chen, J., Zeng, L., Xia, T., Li, S., Yan, T., Wu, S., Qiu, G. & Liu, rats. International Journal of Pharmaceutical & Biological
Z. 2015. Toward a biomarker of oxidative stress: A fluorescent Archive 1: 271-279.
probe for exogenous and endogenous malondialdehyde in Ridtitid, W., Ruangsang, P., Reanmongkol, W. & Wongnawa,
living cells. Analytical Chemistry 87: 8052-8056. M. 2007. Studies of the anti-inflammatory and antipyretic
Davidge, S.T., de Groot, C.J. & Taylor, R.N. 2015. Endothelial activities of the methanolic extract of Piper sarmentosum
cell dysfunction. Chesley’s Hypertensive Disorders in Roxb. leaves in rats. Songklanakarin Journal of Science &
Pregnancy (4th ed.) Elsevier. pp. 181-207. Technology 29: 1519-1526.
Dohi, Y., Thiel, M.A., Bühler, F. & Lüscher, T. 1990. Activation Rincon, J., Correia, D., Arcaya, J., Finol, E., Fernández, A., Pérez,
of endothelial L-arginine pathway in resistance arteries. M., Yaguas, K., Talavera, E., Chávez, M. & Summer, R. 2015.
Effect of age and hypertension. Hypertension 16: 170-179. Role of angiotensin II type 1 receptor on renal NAD (P) H
Drummond, G.R. & Sobey, C.G. 2014. Endothelial NADPH oxidase, oxidative stress and inflammation in nitric oxide
inhibition induced-hypertension. Life Sciences 124: 81-90.
oxidases: Which NOX to target in vascular disease? Trends
Rodrigo, R., Brito, R. & González, J. 2016. Oxidative stress and
in Endocrinology & Metabolism 25: 452-463.
essential hypertension. In Update on Essential Hypertension.
García-Redondo, A.B., Aguado, A., Briones, A.M. & Salaices,
InTech.
M. 2016. NADPH oxidases and vascular remodeling in
Si, H. & Liu, D. 2008. Genistein, a soy phytoestrogen, upregulates
cardiovascular diseases. Pharmacological Research 114:
the expression of human endothelial nitric oxide synthase and
110-120.
lowers blood pressure in spontaneously hypertensive rats. The
Hafizah, A.H., Zaiton, Z., Zulkhairi, A., Ilham, A.M., Anita,
Journal of Nutrition 138: 297-304.
M.M.N.N. & Zaleha, A.M. 2010. Piper sarmentosum as
Sinha, N. & Kumar Dabla, P. 2015. Oxidative stress and
an antioxidant on oxidative stress in human umbilical vein
antioxidants in hypertension - A current review. Current
endothelial cells induced by hydrogen peroxide. Journal of
Hypertension Reviews 11: 132-142.
Zhejiang University SCIENCE B 11: 357-365. Tsai, I.C., Pan, Z.C., Cheng, H.P., Liu, C.H., Lin, B.T. & Jiang,
Hogg, N., Zielonka, J. & Kalyanaraman, B. 2017. Detection of M.J. 2016. Reactive oxygen species derived from NADPH
nitric oxide and peroxynitrite in biological systems: A state- oxidase 1 and mitochondria mediate angiotensin II-induced
of-the-art review. Nitric Oxide. 3rd ed. Elsevier. pp. 23-44. smooth muscle cell senescence. Journal of Molecular and
Hussain, K., Ismail, Z., Sadikun, A., Ibrahim, P. & Malik, A. 2015. Cellular Cardiology 98: 18-27.
In vitro antiangiogenesis activity of standardized extracts of Ugusman, A., Zakaria, Z., Chua, K.H., Nordin, M.M., Anita, N.
Piper sarmentosum roxb. Jurnal Riset Kimia 1: 146. & Abdullah Mahdy, Z. 2014. Role of rutin on nitric oxide
Kumar, K.V. & Das, U. 1993. Are free radicals involved in the synthesis in human umbilical vein endothelial cells. The
pathobiology of human essential hypertension? Free Radical Scientific World Journal 2014: 169370.
Research 19: 59-66. Ugusman, A., Zakaria, Z., Hui, C.K., Nordin, N.A.M.M. &
Mendis, S. 2014. Global Status Report on Noncommunicable Mahdy, Z.A. 2012. Flavonoids of Piper sarmentosum and
Diseases 2014. World Health Organization. its cytoprotective effects against oxidative stress. EXCLI
Mohamad Asri, S.F., Mohd Ramli, E.S., Soelaiman, I.N., Journal 11: 705.
Mat Noh, M.A., Abdul Rashid, A.H. & Suhaimi, F. Ugusman, A., Zakaria, Z., Hui, C.K. & Nordin, N.A.M.M. 2010.
2016. Piper sarmentosum effects on 11β-Hydroxysteroid Piper sarmentosum increases nitric oxide production in
dehydrogenase type 1 enzyme in serum and bone in rat oxidative stress: A study on human umbilical vein endothelial
model of glucocorticoid-induced osteoporosis. Molecules cells. Clinics 65: 709-714.
21(11): 1523. Vanhoutte, P., Shimokawa, H., Feletou, M. & Tang, E. 2017.
Mohd Zainudin, M., Zakaria, Z., Nordin, M.M., Anita, N. & Endothelial dysfunction and vascular disease - a 30th
Othman, F. 2013. Does oral ingestion of Piper sarmentosum anniversary update. Acta Physiologica 219: 22-96.
cause toxicity in experimental animals? Evidence-Based Wheal, A., Bennett, T., Randall, M. & Gardiner, S. 2007.
Complementary and Alternative Medicine 2013: 705950. Effects of chronic nitric oxide synthase inhibition on the
Panth, N., Paudel, K.R. & Parajuli, K. 2016. Reactive oxygen cardiovascular responses to cannabinoids in vivo and in vitro.
species: A key hallmark of cardiovascular disease. Advances British Journal of Pharmacology 150: 662-671.
in Medicine 2016: 9152732. WHO. 2012. World Health Statistic 2012.
Panza, J.A., Quyyumi, A.A., Brush Jr, J.E. & Epstein, S.E. 1990. Yang, H.Y., Yang, S.C., Chen, S.T. & Chen, J.R. 2008. Soy
Abnormal endothelium-dependent vascular relaxation in protein hydrolysate ameliorates cardiovascular remodeling
patients with essential hypertension. New England Journal in rats with L-NAME-induced hypertension. The Journal of
of Medicine 323: 22-27. Nutritional Biochemistry 19: 833-839.
2428
Zainudin, M.M., Zakaria, Z. & Nordin, N.A.M.M. 2015. The use Aminuddin Abdul Hamid Karim
of Piper sarmentosum leaves aqueous extract (Kadukmy™) Physiology Unit
as antihypertensive agent in spontaneous hypertensive rats. Universiti Pertahanan Nasional Malaysia
BMC Complementary and Alternative Medicine 15: 54. 57000 Kuala Lumpur, Federal Territory
Zakaria, Z., Patahuddin, H., Mohamad, A., Israf, D. & Sulaiman, Malaysia
M. 2010. In vivo anti-nociceptive and anti-inflammatory
activities of the aqueous extract of the leaves of Piper Nik Aloesnisa Nik Mohd Alwi
sarmentosum. Journal of Ethnopharmacology 128: 42-48. Basic Science and Oral Biology Unit
School of Dental Sciences
Universiti Sains Malaysia
Nik Aloesnisa Nik Mohd Alwi, Zaiton Zakaria, Nor Anita Megat 16150 Kubang Kerian, Kelantan Darul Naim
Mohd Nordin & Azizah Ugusman* Malaysia
Department of Physiology, Faculty of Medicine
Universiti Kebangsaan Malaysia Medical Centre *Corresponding author; email: [email protected]
Jalan Yaacob Latiff, Bandar Tun Razak, Cheras
56000 Kuala Lumpur, Federal Territory Received: 25 March 2018
Malaysia Accepted: 6 June 2018